Finland Joins Sweden, Denmark In Cutting Use Of Moderna Vaccine

Finland on Thursday paused the use of Moderna's COVID-19 vaccine for younger males due to reports of a rare cardiovascular side effect, joining Sweden and Denmark in limiting its use, Essi Lehto and Emilio Parodi reported for Reuters.

Photo Insert: A study found that men under the age of 30 who received Moderna Spikevax had a slightly higher risk than others of developing myocarditis

Mika Salminen, director of the Finnish health institute, said Finland would instead give Pfizer's vaccine to men born in 1991 and later. Finland offers shots to people aged 12 and over.

"A Nordic study involving Finland, Sweden, Norway, and Denmark found that men under the age of 30 who received Moderna Spikevax had a slightly higher risk than others of developing myocarditis," he said.

Swedish and Danish health officials had announced on Wednesday they would pause the use of the Moderna vaccine for all young adults and children, citing the same unpublished study. Norwegian health officials reiterated on Wednesday that they recommended men under the age of 30 opt for Pfizer's vaccine.

The Finnish institute said the Nordic study would be published within a couple of weeks and preliminary data had been sent to the European Medicines Agency (EMA) for further assessment.

The EMA's safety committee concluded in July that such inflammatory heart conditions could occur in very rare cases following vaccination with Spikevax or the Pfizer/BioNTech Comirnaty jab, more often among younger men after the second dose.

WEEKLY FEATURE : MVP Group Keeps Lights On During Pandemic